Passa al contenuto
Merck

Prednicarbate (dermatop): a review.

Journal of drugs in dermatology : JDD (2004-11-24)
Aditya K Gupta, Melody Chow
ABSTRACT

Prednicarbate is a non-halogenated, double-ester derivative of prednisolone that has become of interest for the treatment of inflammatory skin diseases, for example atopic dermatitis. In the past, topical steroids have been a popular choice for treating these diseases; however, the potential for significant local and systemic adverse events, such as skin atrophy and hypothalamic-pituitary-adrenal (HPA) axis suppression have limited their use. Prednicarbate has been found to have a favorable benefit-risk ratio, with low skin atrophy potential, and a high anti-inflammatory action. Prednicarbate may be particularly advantageous when used intermittently in pediatric and elderly patients.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Prednicarbate for system suitability A, European Pharmacopoeia (EP) Reference Standard
Prednicarbate, European Pharmacopoeia (EP) Reference Standard